IN-VITRO BUT NOT IN-VIVO INHIBITION OF CYP2D6 BY PHENETHYL ISOTHIOCYANATE (PEITC), A CONSTITUENT OF WATERCRESS

被引：14

作者：

CAPORASO, N

WHITEHOUSE, J

MONKMAN, S

BOUSTEAD, C

ISSAQ, H

FOX, S

MORSE, MA

IDLE, JR

CHUNG, FL

机构：

[1] AMER HLTH FDN,VALHALLA,NY 10595

[2] UNIV NEWCASTLE UPON TYNE,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND

[3] NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES INC DYNCORP,CHEM SYNTH & ANAL LAB,FREDERICK,MD 21702

来源：

PHARMACOGENETICS | 1994年 / 4卷 / 05期

关键词：

D O I：

10.1097/00008571-199410000-00006

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：275 / 280

页数：6

共 40 条

[1] DEBRISOQUIN OXIDATION GENOTYPE AND SUSCEPTIBILITY TO LUNG-CANCER [J].

AGUNDEZ, JAG ;

MARTINEZ, C ;

LADERO, JM ;

LEDESMA, MC ;

RAMOS, JM ;

MARTIN, R ;

RODRIGUEZ, A ;

JARA, C ;

BENITEZ, J .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (01) :10-14

[2] HYDROXYLATION POLYMORPHISMS OF DEBRISOQUINE AND MEPHENYTOIN IN EUROPEAN POPULATIONS [J].

ALVAN, G ;

BECHTEL, P ;

ISELIUS, L ;

GUNDERTREMY, U .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (06) :533-537

[3]

AYESH R, 1984, NATURE, V312, P1669

[4] POLYMORPHIC OXIDATION OF DEBRISOQUINE IN BLADDER-CANCER [J].

BENITEZ, J ;

LADERO, JM ;

FERNANDEZGUNDIN, MJ ;

LLERENA, A ;

COBALEDA, J ;

MARTINEZ, C ;

MUNOZ, JJ ;

VARGAS, E ;

PRADOS, J ;

GONZALEZROZAS, F ;

RODRIGUEZMOLINA, J ;

USON, AC .

ANNALS OF MEDICINE, 1990, 22 (03) :157-160

[5] EXTENSIVE METABOLIZERS OF DEBRISOQUINE BECOME POOR METABOLIZERS DURING QUINIDINE TREATMENT [J].

BROSEN, K ;

GRAM, LF ;

HAGHFELT, T ;

BERTILSSON, L .

PHARMACOLOGY & TOXICOLOGY, 1987, 60 (04) :312-314

[6] THE DISTRIBUTION OF DEBRISOQUINE METABOLIC PHENOTYPES AND IMPLICATIONS FOR THE SUGGESTED ASSOCIATION WITH LUNG-CANCER RISK [J].

CAPORASO, N ;

PICKLE, LW ;

BALE, S ;

AYESH, R ;

HETZEL, M ;

IDLE, J .

GENETIC EPIDEMIOLOGY, 1989, 6 (04) :517-524

[7]

CAPORASO N, 1991, ARCH INTERN MED, V191, P1985

[8]

CAPORASO N, 1992, P AM ASSOC CANC RES, V33, P1733

[9] LUNG-CANCER AND THE DEBRISOQUINE METABOLIC PHENOTYPE [J].

CAPORASO, NE ;

TUCKER, MA ;

HOOVER, RN ;

HAYES, RB ;

PICKLE, LW ;

ISSAQ, HJ ;

MUSCHIK, GM ;

GREENGALLO, L ;

BUIVYS, D ;

AISNER, S ;

RESAU, JH ;

TRUMP, BF ;

TOLLERUD, D ;

WESTON, A ;

HARRIS, CC .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (15) :1264-1272

[10] GENETICALLY-DETERMINED DEBRISOQUINE OXIDATION CAPACITY IN BLADDER-CANCER [J].

CARTWRIGHT, RA ;

PHILIP, PA ;

ROGERS, HJ ;

GLASHAN, RW .

CARCINOGENESIS, 1984, 5 (09) :1191-1192

← 1 2 3 4 →